NT-pro-BNP levels as a marker of success of percutaneous transvenous mitral commissurotomy

Indian Heart J. 2010 Jan-Feb;62(1):35-8.

Abstract

Background: Brain natriureticpeptide (BNP) levels are elevated in patients with rheumatic mitral stenosis (MS) and decrease after a successful percutaneous transvenous mitral commissurotomy (PTMC).

Methods: In 37 consecutive patients of symptomatic MS (mean age 30 +/- 8.6 years) NTpro BNP levels were determined pre and 24-hours post PTMC. We seek to determine whether NT-pro-BNP levels be used as a marker of success of PTMC.

Results: PTMC was successful orpartial successful in 33 (89 %) cases. The mean NT-pro- BNP levels decreasedfrom 771 +/- 456 pg/ml to 700 +/- 595 pg/ml (p < 0.05) following PTMC. The mean NT-pro-BNP levels decreased by 20.6% in patients with a successful PTMC and decreased by 10.8% in patients with a partially successful PTMC, while the levels increased by 33.4% in patients with an unsuccessful procedure. Patients with associated aortic regurgitation failed to show a decline in NT-pro-BNP levels despite a successful procedure.

Conclusion: NT-pro-BNP levels fall significantly after a successful PTMC, and a significant decrease in levels is a good marker of success of PTMC. It may not decrease in patients with associated aortic regurgitation despite a successfiul PTMC.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Catheterization*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve Stenosis / blood
  • Mitral Valve Stenosis / therapy*
  • Natriuretic Peptide, Brain / blood*
  • Peptide Fragments / blood*
  • Protein Precursors
  • Treatment Outcome

Substances

  • Peptide Fragments
  • Protein Precursors
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain